Chinese Private Aesthetic Medical Firm Yestar Delays HK IPO As Market Turmoil Strikes

Eudora Wang
October 16, 2018 — 11:49 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: aesthetic medical China chinese finance healthcare Hong Kong IPO news media Plastic Surgery revenue stock exchange Yestar

Related News:

Chinese EV Maker CHJ Automotive Files For US IPO

January 3, 2020 — 21:08

Chinese Debt Collection Firm YX Eyes $200M In US IPO

October 31, 2019 — 15:28

Hillhouse-Backed Biotech Firm I-Mab Eyes $100M In US IPO

October 30, 2019 — 17:04

Bitcoin Mining-Related Firm Canaan Seeks To Raise US$400M In US IPO

October 29, 2019 — 18:40

Ant Financial-Backed O2O Rental Housing Platform Danke Apartment Files For US IPO

October 29, 2019 — 12:37

CICC Completes The First Counselling Report Of AI Unicorn Unisound’s IPO

October 18, 2019 — 18:04

Chinese Online Insurance Platform Huize Files US IPO Eyeing Up To $150M

September 5, 2019 — 11:27

Five Remarkable Facts From Chinese AI Unicorn Megvii’s IPO Prospectus

August 26, 2019 — 15:24

Hong Kong-Based Financial Services Firm AMTD Sets Terms For $172M New York IPO

July 30, 2019 — 14:24